MaSTherCell Appointed as Process Development and Manufacturing Partner for Zelluna Immunotherapy’s TCR … – Markets Insider
|
MaSTherCell Appointed as Process Development and Manufacturing Partner for Zelluna Immunotherapy's TCR …
Markets Insider GERMANTOWN, Md., March 19, 2018 (GLOBE NEWSWIRE) — Orgenesis Inc. (Nasdaq:ORGS), a manufacturer, service provider and developer of advanced cell therapies, today announced that its manufacturing subsidiary, MaSTherCell S.A. (“MaSTherCell”) was … |
